Celebrex

Arthritis and Joint Conditions

Celebrex is primarily prescribed to manage the symptoms of several types of arthritis. It helps reduce pain, stiffness, and swelling in the joints for people with the following conditions:

• Osteoarthritis: A condition where the protective cartilage on the ends of bones wears down over time.
• Rheumatoid arthritis: An autoimmune disorder that causes chronic inflammation of the joints.
• Ankylosing spondylitis: A type of arthritis that primarily affects the spine, leading to pain and stiffness.
• Juvenile rheumatoid arthritis: Used in children aged 2 years and older to manage symptoms of this chronic inflammatory condition.

Pain Management

Beyond chronic joint conditions, Celebrex is used for the short-term treatment of acute pain. This may include pain resulting from injuries or medical procedures. It is also commonly used to treat primary dysmenorrhea, which is the medical term for painful menstrual cramps.

Mechanism of Action

Celebrex belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). Specifically, it is categorized as a COX-2 inhibitor.

The body produces enzymes called cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). These enzymes play different roles in the body:

• COX-1: This enzyme helps maintain the lining of the stomach and supports kidney function.
• COX-2: This enzyme is primarily responsible for producing prostaglandins, which are chemicals that trigger pain, fever, and inflammation in response to injury or disease.

Celebrex works by selectively blocking the COX-2 enzyme. By reducing the amount of prostaglandins the body produces, the medication helps decrease swelling and relieve pain associated with conditions like arthritis.

Because Celebrex is designed to target COX-2 more than COX-1, it may have a lower risk of causing certain stomach-related side effects compared to traditional NSAIDs that block both enzymes. However, it still carries risks common to the NSAID class, and its effects on the body can vary depending on the individual.

Common Side Effects

While taking Celebrex, some individuals may experience mild symptoms. Common side effects include:

• Stomach issues such as gas, bloating, or diarrhea
• Constipation
• Dizziness
• Cold symptoms, including a sore throat or runny nose
• Swelling in the hands, ankles, or feet

Serious Side Effects

Some side effects can be severe. Seek medical attention immediately if you experience:

• Signs of an allergic reaction, such as a skin rash, hives, or swelling of the face, lips, or tongue
• Chest pain, shortness of breath, or sudden weakness on one side of the body
• Slurred speech or vision changes
• Severe stomach pain or stools that are black, tarry, or contain blood
• Yellowing of the skin or eyes
• Unexplained weight gain or changes in the amount of urine

Boxed Warnings

Cardiovascular Risk: Nonsteroidal anti-inflammatory drugs (NSAIDs), including Celebrex, may increase the risk of serious cardiovascular thrombotic events, such as heart attack and stroke, which can be fatal. This risk may increase with longer use or in patients with existing heart disease or risk factors for heart disease.

Gastrointestinal Risk: Celebrex increases the risk of serious gastrointestinal (GI) events, including bleeding, ulceration, and perforation of the stomach or intestines. These events can be fatal and may occur at any time during use without warning symptoms. Older adults and those with a history of stomach ulcers are at higher risk.

Contraindications

• Heart Surgery: This medication should not be used to treat pain right before or after heart bypass surgery (coronary artery bypass graft, or CABG).
• Allergies: It should not be used by individuals with a known allergy to celecoxib or sulfonamides. It is also contraindicated for those who have experienced asthma, hives, or other allergic reactions after taking aspirin or other NSAIDs.

Other Precautions

Heart and Kidney Health: Celebrex can cause or worsen high blood pressure and fluid retention. It should be used with caution in individuals with heart failure, kidney disease, or liver impairment. Long-term use may require regular monitoring of kidney and liver function by a healthcare professional.

Pregnancy: Use of this medication is generally discouraged starting at 20 weeks of pregnancy, as it may cause rare but serious kidney problems in the unborn baby. It should be strictly avoided after 30 weeks of pregnancy due to the risk of premature closure of a vital heart vessel in the fetus.

Skin Reactions: Serious and sometimes fatal skin reactions, such as exfoliative dermatitis or Stevens-Johnson syndrome, can occur. Treatment is typically discontinued at the first sign of a skin rash or any other sign of hypersensitivity.

Pregnancy

Medical professionals generally advise against using Celebrex starting at 20 weeks of pregnancy. Research indicates that using nonsteroidal anti-inflammatory drugs (NSAIDs) during this period can cause rare but serious kidney issues in the unborn baby, potentially leading to low levels of amniotic fluid.

Avoidance is especially critical at 30 weeks or later, as the medication may cause a vital heart vessel in the baby, known as the ductus arteriosus, to close too early. Furthermore, Celebrex may temporarily impact fertility by interfering with ovulation.

Breastfeeding

Celebrex is known to pass into breast milk in small quantities. While it is often considered compatible with nursing, it is important to consult a healthcare provider to weigh the benefits of treatment against potential risks to the infant.

Dosage Forms

Celebrex is supplied in the following form:

• Oral Capsule: This medication is taken by mouth as directed by a healthcare professional.

The capsules are generally swallowed whole. For patients who have difficulty swallowing capsules, the medication may be opened and the contents sprinkled onto a small amount of soft food, such as applesauce, to be swallowed immediately.

FDA Approval and Indications

Celebrex (celecoxib) is approved by the U.S. Food and Drug Administration (FDA) for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and juvenile rheumatoid arthritis in patients 2 years of age and older. It is also indicated for the management of acute pain in adults and the treatment of primary dysmenorrhea (menstrual cramps).

Boxed Warning

The FDA requires a boxed warning for Celebrex, which is the most serious type of warning, to alert healthcare providers and patients to the following risks:

• Cardiovascular Risk: Nonsteroidal anti-inflammatory drugs (NSAIDs), including Celebrex, cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may occur early in treatment and may increase with the duration of use.
• Gastrointestinal Risk: NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at greater risk.

Safety Communications

In 2018, the FDA approved a labeling supplement for Celebrex based on the results of the PRECISION trial. This large-scale clinical trial evaluated the cardiovascular safety of celecoxib compared to ibuprofen and naproxen in patients with osteoarthritis or rheumatoid arthritis who were at high risk for cardiovascular disease. The updated labeling reflects the findings regarding the relative safety profile of these medications in that specific patient population.

Brand vs. Generic Availability

Celebrex is available as both a brand-name medication and a generic version called celecoxib. Generic drugs are typically much less expensive than brand-name versions while providing the same therapeutic benefits. Most insurance plans cover the generic version of this medication.

Factors Influencing Cost

The amount you pay for Celebrex or its generic equivalent can be affected by several factors:

• Insurance Coverage: Your out-of-pocket costs will depend on your insurance provider's formulary, your deductible, and your specific copay or coinsurance rates.
• Dosage and Quantity: The strength of the capsules (ranging from 50 mg to 400 mg) and the total number of capsules in the prescription will impact the price.
• Pharmacy Selection: Prices can vary between retail pharmacies, and some mail-order pharmacy services may offer lower rates for 90-day supplies.

Financial Assistance Programs

For individuals who are uninsured or underinsured, there may be options to reduce the cost of the medication. The manufacturer of brand-name Celebrex sometimes offers savings cards or patient assistance programs. Additionally, many pharmacies accept third-party coupons or offer their own discount programs for generic celecoxib.